Gut dysbiosis in Down syndrome: A potentially unexplored culprit for early Alzheimer's disease
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Herminia Diana Rosas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA. Hauptthemen laut MEDLINE: Down Syndrome, Dysbiosis, Gastrointestinal Microbiome, Alzheimer Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, Libbi Thomas Foundation.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Gut dysbiosis has been found to play a role in sporadic Alzheimer's disease (AD) but has not been explored in Down syndrome (DS), despite the strong relationship between DS and early AD. Here, we compared the gut microbiomes of 20 adults with DS, either cognitively stable or with mild cognitive impairment. METHODS DNA from stool samples was profiled using 16S rRNA sequencing. RESULTS Cognitive status was associated with a significant difference in overall microbiome composition ( p < 0.01) and with significant differences in the abundance of Bacteroidaceae, Enterobacteriaceae, and Christensenellaceae. CONCLUSION Just as in sporadic AD, AD in DS is associated with gut dysbiosis. Our work suggests that this is an important area for future investigation, one that may provide a novel and important target for therapeutic intervention. Highlights Alterations in the gut microbiome are present in adults with Down syndrome (DS) with mild cognitive impairment (MCI). Increased taxa in DS‐MCI that contribute to inflammation and disrupt blood–brain barrier. Suggests a possible role of gut dysbiosis in Alzheimer's disease in adults with DS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA.
- Center for Neuroimaging of Aging and Neurodegenerative Diseases, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA.
- Microbiome Analysis Core, Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA.
Förderung
- NIA NIH HHS
- NIH HHS
- Libbi Thomas Foundation
- National Institutes of Health
- National Institute on Aging
Zitieren
APA
Rosas, H. D., Morgan, X. C., Tao, Y., Lai, F., & Mercaldo, N. D. (2025). Gut dysbiosis in Down syndrome: A potentially unexplored culprit for early Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70330
Vancouver
Rosas HD, Morgan XC, Tao Y, Lai F, Mercaldo ND. Gut dysbiosis in Down syndrome: A potentially unexplored culprit for early Alzheimer's disease. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70330
BibTeX
@article{Rosas2025,
author = {Rosas, Herminia Diana and Morgan, Xochitl C and Tao, Yiran and Lai, Florence and Mercaldo, Nathaniel D},
title = {Gut dysbiosis in Down syndrome: A potentially unexplored culprit for early Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70330}
}
EUVIMED